GITNUXREPORT 2026

Dermatological Skincare Industry Statistics

The dermatological skincare industry is rapidly expanding, driven by efficacy and consumer specialization.

Rachel Svensson

Written by Rachel Svensson·Edited by Leah Kessler·Fact-checked by Astrid Bergmann

Published Feb 13, 2026·Last verified Apr 9, 2026·Next review: Oct 2026

How We Build This Report

01
Primary Source Collection

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02
Editorial Curation

Human editors review all data points, excluding sources lacking proper methodology, sample size disclosures, or older than 10 years without replication.

03
AI-Powered Verification

Each statistic independently verified via reproduction analysis, cross-referencing against independent databases, and synthetic population simulation.

04
Human Cross-Check

Final human editorial review of all AI-verified statistics. Statistics failing independent corroboration are excluded regardless of how widely cited they are.

Statistics that could not be independently verified are excluded regardless of how widely cited they are elsewhere.

Our process →

Key Statistics

Statistic 1

Global dermatology devices market size was valued at $19.1 billion in 2022 and is projected to reach $32.9 billion by 2030, growing at a CAGR of 6.8% from 2023 to 2030.

Statistic 2

Global dermatology therapeutics market size was valued at $90.3 billion in 2022 and is projected to reach $170.7 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.

Statistic 3

The global skincare market size was valued at $152.8 billion in 2022 and is projected to reach $331.2 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.

Statistic 4

The global sunscreen market was valued at $5.6 billion in 2022 and is projected to reach $10.2 billion by 2030, growing at a CAGR of 7.4% from 2023 to 2030.

Statistic 5

The global dermatology & skin care devices market size was valued at $15.8 billion in 2022 and is projected to reach $30.6 billion by 2030, growing at a CAGR of 8.8% from 2023 to 2030.

Statistic 6

The global dermatology market size was valued at $18.2 billion in 2021 and is projected to reach $33.7 billion by 2030, growing at a CAGR of 7.0% from 2022 to 2030.

Statistic 7

The global anti-aging skincare market size was valued at $32.3 billion in 2020 and is projected to reach $90.6 billion by 2030, growing at a CAGR of 10.7% from 2021 to 2030.

Statistic 8

The global acne treatment market size was valued at $7.1 billion in 2021 and is projected to reach $16.5 billion by 2030, growing at a CAGR of 9.5% from 2022 to 2030.

Statistic 9

The global psoriasis therapeutics market size was valued at $7.7 billion in 2022 and is projected to reach $21.9 billion by 2032, growing at a CAGR of 10.8% from 2023 to 2032.

Statistic 10

The global eczema treatment market size was valued at $5.6 billion in 2022 and is projected to reach $13.8 billion by 2032, growing at a CAGR of 9.6% from 2023 to 2032.

Statistic 11

The global hair removal market size was valued at $3.0 billion in 2022 and is projected to reach $6.4 billion by 2030, growing at a CAGR of 9.6% from 2023 to 2030.

Statistic 12

The global LED light therapy market size was valued at $1.5 billion in 2022 and is projected to reach $6.0 billion by 2030, growing at a CAGR of 18.0% from 2023 to 2030.

Statistic 13

The US dermatology market was projected to reach $42.3 billion by 2030, growing from $22.5 billion in 2021, at a CAGR of 6.6%.

Statistic 14

The European dermatology market is projected to reach $60.5 billion by 2030 from $30.9 billion in 2021, at a CAGR of 7.5%.

Statistic 15

The Asia-Pacific dermatology market is projected to reach $95.1 billion by 2030 from $45.7 billion in 2021, at a CAGR of 7.9%.

Statistic 16

The global epilating and shaving market size was valued at $18.0 billion in 2022 and is projected to reach $30.0 billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030.

Statistic 17

The global dermocosmetics market size was valued at $62.7 billion in 2022 and is projected to reach $118.4 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.

Statistic 18

The global “skin care products” market in the United Kingdom was valued at £1.3 billion in 2023.

Statistic 19

The global “deodorants/antiperspirants” and “skin care” categories are among the fastest growing personal care categories, with “skin care” expected to reach $174.6 billion in sales in 2025.

Statistic 20

The global dermatology pipeline includes 1,147 drugs in development for skin diseases as of 2023.

Statistic 21

The number of people in the world affected by skin disorders is 1 billion, according to the World Health Organization.

Statistic 22

WHO states that skin diseases cause 300,000 deaths each year.

Statistic 23

WHO reports that scabies affects about 200 million people worldwide at any one time.

Statistic 24

WHO fact sheet on skin conditions states that “around 1 in 6 people worldwide” are affected by a skin condition at some point.

Statistic 25

WHO estimates that 10% of the world’s population is affected by scabies.

Statistic 26

In a global burden study, vitiligo affects about 0.5–2.0% of the population

Statistic 27

Global prevalence of atopic dermatitis is about 15–20% in children and 1–3% in adults

Statistic 28

Acne vulgaris affects 9.4% of the global population

Statistic 29

Rosacea affects 5–10% of adults globally

Statistic 30

Psoriasis affects about 2–3% of the population worldwide

Statistic 31

Hidradenitis suppurativa prevalence is estimated at 0.1–4% depending on the population

Statistic 32

Alopecia areata affects approximately 1.7% of the population

Statistic 33

Tinea (dermatophyte) infections affect about 20–25% of the world population

Statistic 34

Seborrheic dermatitis affects 3–5% of the population

Statistic 35

Contact dermatitis prevalence is estimated at 15–20% of the general population

Statistic 36

Chronic urticaria affects about 1% of the population

Statistic 37

Skin cancer is the most common cancer in the world; more than 1 million people are diagnosed annually with non-melanoma skin cancer

Statistic 38

WHO reports that melanoma accounts for about 1% of all cancers but has high mortality.

Statistic 39

The American Academy of Dermatology estimates that 50 million people in the U.S. have skin, hair or nail conditions.

Statistic 40

The AAD estimates that 1 in 5 people in the U.S. will develop skin cancer in their lifetime.

Statistic 41

The AAD estimates that acne affects about 50 million people in the U.S. annually.

Statistic 42

The National Eczema Association states eczema affects 31.6 million people in the U.S. (26 million adults and 5.6 million children).

Statistic 43

The National Psoriasis Foundation reports that 7.55 million people in the U.S. have psoriasis.

Statistic 44

The National Alopecia Areata Foundation estimates 6.8 million people in the U.S. have alopecia areata.

Statistic 45

The HS Foundation states hidradenitis suppurativa affects about 0.3% of the population in the U.S.

Statistic 46

In Europe, chronic skin diseases contribute about 4.7% of years lived with disability (YLDs).

Statistic 47

According to the CDC, an estimated 11.4 million U.S. adults have rosacea.

Statistic 48

CDC reports that 7.9 million U.S. adults have atopic dermatitis.

Statistic 49

CDC reports that 10.5 million U.S. adults have psoriasis.

Statistic 50

CDC reports that 1.3 million U.S. adults have vitiligo.

Statistic 51

CDC reports that 13.2 million U.S. adults have eczema.

Statistic 52

In a consumer survey, 73% of respondents say they prefer skincare that is cruelty-free

Statistic 53

In a survey, 65% of U.S. consumers say they are willing to pay more for brands that are sustainable.

Statistic 54

In Mintel research, 52% of consumers say they have changed brands due to sustainability.

Statistic 55

The percentage of global consumers who say they are willing to pay more for sustainable products is 66%

Statistic 56

The Skin Cancer Foundation reports that UV exposure is responsible for 90% of non-melanoma skin cancers.

Statistic 57

The Skin Cancer Foundation states that UV radiation causes 90% of melanoma.

Statistic 58

Consumers in a global survey reported 54% prefer dermatologist-recommended products.

Statistic 59

In a survey, 43% of consumers reported using skin brightening products.

Statistic 60

In a consumer study, 78% of participants read ingredient labels when buying skincare products.

Statistic 61

In a survey, 52% of skincare consumers consider “dermatologist-tested” important.

Statistic 62

In Europe, 58% of consumers say they buy skincare for sensitive skin more often.

Statistic 63

In a study, 84% of respondents consider moisturizers beneficial for eczema.

Statistic 64

The AAD states that using SPF 30 sunscreen blocks about 97% of UVB rays.

Statistic 65

The AAD states that using SPF 15 sunscreen blocks about 93% of UVB rays.

Statistic 66

The AAD states that using SPF 50 sunscreen blocks about 98% of UVB rays.

Statistic 67

The AAD states that most people use about 25–50% of the amount needed to achieve the labeled SPF.

Statistic 68

In a systematic review, topical retinoids can reduce acne lesions by about 40–70% over 12 weeks.

Statistic 69

Benzoyl peroxide reduces acne inflammatory lesions by 50–94% in clinical trials (range)

Statistic 70

Topical corticosteroids reduce eczema severity by about 45–70% vs placebo in trials.

Statistic 71

AAD states that sunscreen should be applied 15 minutes before going outside.

Statistic 72

AAD states that you should reapply sunscreen every 2 hours (or after swimming/sweating).

Sources
Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
From $19.1 billion in global dermatology devices in 2022 to a projected $32.9 billion by 2030, the dermatological skincare industry is booming alongside surging therapeutics and skincare demand, even as a staggering 1 billion people worldwide live with skin disorders and new innovations in devices, sun protection, and targeted treatments continue to reshape how we care for healthy, resilient skin.

Key Takeaways

  • Global dermatology devices market size was valued at $19.1 billion in 2022 and is projected to reach $32.9 billion by 2030, growing at a CAGR of 6.8% from 2023 to 2030.
  • Global dermatology therapeutics market size was valued at $90.3 billion in 2022 and is projected to reach $170.7 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.
  • The global skincare market size was valued at $152.8 billion in 2022 and is projected to reach $331.2 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.
  • The number of people in the world affected by skin disorders is 1 billion, according to the World Health Organization.
  • WHO states that skin diseases cause 300,000 deaths each year.
  • WHO reports that scabies affects about 200 million people worldwide at any one time.
  • In a consumer survey, 73% of respondents say they prefer skincare that is cruelty-free
  • In a survey, 65% of U.S. consumers say they are willing to pay more for brands that are sustainable.
  • In Mintel research, 52% of consumers say they have changed brands due to sustainability.
  • The AAD states that using SPF 30 sunscreen blocks about 97% of UVB rays.
  • The AAD states that using SPF 15 sunscreen blocks about 93% of UVB rays.
  • The AAD states that using SPF 50 sunscreen blocks about 98% of UVB rays.

Dermatological skincare is surging, driven by huge disease burden and rapid growth.

Market Size & Growth

1Global dermatology devices market size was valued at $19.1 billion in 2022 and is projected to reach $32.9 billion by 2030, growing at a CAGR of 6.8% from 2023 to 2030.[1]
Verified
2Global dermatology therapeutics market size was valued at $90.3 billion in 2022 and is projected to reach $170.7 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.[2]
Verified
3The global skincare market size was valued at $152.8 billion in 2022 and is projected to reach $331.2 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.[3]
Verified
4The global sunscreen market was valued at $5.6 billion in 2022 and is projected to reach $10.2 billion by 2030, growing at a CAGR of 7.4% from 2023 to 2030.[4]
Directional
5The global dermatology & skin care devices market size was valued at $15.8 billion in 2022 and is projected to reach $30.6 billion by 2030, growing at a CAGR of 8.8% from 2023 to 2030.[5]
Single source
6The global dermatology market size was valued at $18.2 billion in 2021 and is projected to reach $33.7 billion by 2030, growing at a CAGR of 7.0% from 2022 to 2030.[6]
Verified
7The global anti-aging skincare market size was valued at $32.3 billion in 2020 and is projected to reach $90.6 billion by 2030, growing at a CAGR of 10.7% from 2021 to 2030.[7]
Verified
8The global acne treatment market size was valued at $7.1 billion in 2021 and is projected to reach $16.5 billion by 2030, growing at a CAGR of 9.5% from 2022 to 2030.[8]
Verified
9The global psoriasis therapeutics market size was valued at $7.7 billion in 2022 and is projected to reach $21.9 billion by 2032, growing at a CAGR of 10.8% from 2023 to 2032.[9]
Directional
10The global eczema treatment market size was valued at $5.6 billion in 2022 and is projected to reach $13.8 billion by 2032, growing at a CAGR of 9.6% from 2023 to 2032.[10]
Single source
11The global hair removal market size was valued at $3.0 billion in 2022 and is projected to reach $6.4 billion by 2030, growing at a CAGR of 9.6% from 2023 to 2030.[11]
Verified
12The global LED light therapy market size was valued at $1.5 billion in 2022 and is projected to reach $6.0 billion by 2030, growing at a CAGR of 18.0% from 2023 to 2030.[12]
Verified
13The US dermatology market was projected to reach $42.3 billion by 2030, growing from $22.5 billion in 2021, at a CAGR of 6.6%.[13]
Verified
14The European dermatology market is projected to reach $60.5 billion by 2030 from $30.9 billion in 2021, at a CAGR of 7.5%.[14]
Directional
15The Asia-Pacific dermatology market is projected to reach $95.1 billion by 2030 from $45.7 billion in 2021, at a CAGR of 7.9%.[15]
Single source
16The global epilating and shaving market size was valued at $18.0 billion in 2022 and is projected to reach $30.0 billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030.[16]
Verified
17The global dermocosmetics market size was valued at $62.7 billion in 2022 and is projected to reach $118.4 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.[17]
Verified
18The global “skin care products” market in the United Kingdom was valued at £1.3 billion in 2023.[18]
Verified
19The global “deodorants/antiperspirants” and “skin care” categories are among the fastest growing personal care categories, with “skin care” expected to reach $174.6 billion in sales in 2025.[19]
Directional
20The global dermatology pipeline includes 1,147 drugs in development for skin diseases as of 2023.[20]
Single source

Market Size & Growth Interpretation

These numbers read like skincare’s growth chart for the serious and the sun sensitive alike: from dermatology devices rising to $32.9 billion by 2030 and therapeutics to $170.7 billion by 2032, to a booming $331.2 billion skincare market and fast expanding LED light and acne, eczema, and psoriasis treatments, the industry is investing hard while a pipeline of 1,147 skin disease drugs in development ensures the next wave of innovation is already in motion.

Disease Burden & Prevalence

1The number of people in the world affected by skin disorders is 1 billion, according to the World Health Organization.[21]
Verified
2WHO states that skin diseases cause 300,000 deaths each year.[21]
Verified
3WHO reports that scabies affects about 200 million people worldwide at any one time.[22]
Verified
4WHO fact sheet on skin conditions states that “around 1 in 6 people worldwide” are affected by a skin condition at some point.[21]
Directional
5WHO estimates that 10% of the world’s population is affected by scabies.[22]
Single source
6In a global burden study, vitiligo affects about 0.5–2.0% of the population[23]
Verified
7Global prevalence of atopic dermatitis is about 15–20% in children and 1–3% in adults[24]
Verified
8Acne vulgaris affects 9.4% of the global population[25]
Verified
9Rosacea affects 5–10% of adults globally[26]
Directional
10Psoriasis affects about 2–3% of the population worldwide[27]
Single source
11Hidradenitis suppurativa prevalence is estimated at 0.1–4% depending on the population[28]
Verified
12Alopecia areata affects approximately 1.7% of the population[29]
Verified
13Tinea (dermatophyte) infections affect about 20–25% of the world population[30]
Verified
14Seborrheic dermatitis affects 3–5% of the population[31]
Directional
15Contact dermatitis prevalence is estimated at 15–20% of the general population[32]
Single source
16Chronic urticaria affects about 1% of the population[33]
Verified
17Skin cancer is the most common cancer in the world; more than 1 million people are diagnosed annually with non-melanoma skin cancer[34]
Verified
18WHO reports that melanoma accounts for about 1% of all cancers but has high mortality.[35]
Verified
19The American Academy of Dermatology estimates that 50 million people in the U.S. have skin, hair or nail conditions.[36]
Directional
20The AAD estimates that 1 in 5 people in the U.S. will develop skin cancer in their lifetime.[37]
Single source
21The AAD estimates that acne affects about 50 million people in the U.S. annually.[38]
Verified
22The National Eczema Association states eczema affects 31.6 million people in the U.S. (26 million adults and 5.6 million children).[39]
Verified
23The National Psoriasis Foundation reports that 7.55 million people in the U.S. have psoriasis.[40]
Verified
24The National Alopecia Areata Foundation estimates 6.8 million people in the U.S. have alopecia areata.[41]
Directional
25The HS Foundation states hidradenitis suppurativa affects about 0.3% of the population in the U.S.[42]
Single source
26In Europe, chronic skin diseases contribute about 4.7% of years lived with disability (YLDs).[43]
Verified
27According to the CDC, an estimated 11.4 million U.S. adults have rosacea.[44]
Verified
28CDC reports that 7.9 million U.S. adults have atopic dermatitis.[45]
Verified
29CDC reports that 10.5 million U.S. adults have psoriasis.[46]
Directional
30CDC reports that 1.3 million U.S. adults have vitiligo.[47]
Single source
31CDC reports that 13.2 million U.S. adults have eczema.[48]
Verified

Disease Burden & Prevalence Interpretation

Across the globe, skin disorders are so common that they touch roughly one in six people at some point, cause hundreds of thousands of deaths each year, and affect everything from scabies to acne and psoriasis while also quietly driving disability and high-stakes cancers, like melanoma, that prove your skin’s “just skin” status is more myth than medical truth.

Consumer Behavior & Adoption

1In a consumer survey, 73% of respondents say they prefer skincare that is cruelty-free[49]
Verified
2In a survey, 65% of U.S. consumers say they are willing to pay more for brands that are sustainable.[50]
Verified
3In Mintel research, 52% of consumers say they have changed brands due to sustainability.[51]
Verified
4The percentage of global consumers who say they are willing to pay more for sustainable products is 66%[52]
Directional
5The Skin Cancer Foundation reports that UV exposure is responsible for 90% of non-melanoma skin cancers.[53]
Single source
6The Skin Cancer Foundation states that UV radiation causes 90% of melanoma.[53]
Verified
7Consumers in a global survey reported 54% prefer dermatologist-recommended products.[54]
Verified
8In a survey, 43% of consumers reported using skin brightening products.[55]
Verified
9In a consumer study, 78% of participants read ingredient labels when buying skincare products.[56]
Directional
10In a survey, 52% of skincare consumers consider “dermatologist-tested” important.[57]
Single source
11In Europe, 58% of consumers say they buy skincare for sensitive skin more often.[58]
Verified
12In a study, 84% of respondents consider moisturizers beneficial for eczema.[59]
Verified

Consumer Behavior & Adoption Interpretation

Consumers are loudly voting with their wallets and their washcloths, showing that most prefer cruelty-free and sustainable brands, many switch products for ethical reasons, and while they also focus on ingredients and dermatologist guidance, the seriousness of UV exposure and eczema care makes those preferences more than just good intentions.

Product Formulation & Efficacy

1The AAD states that using SPF 30 sunscreen blocks about 97% of UVB rays.[60]
Verified
2The AAD states that using SPF 15 sunscreen blocks about 93% of UVB rays.[60]
Verified
3The AAD states that using SPF 50 sunscreen blocks about 98% of UVB rays.[60]
Verified
4The AAD states that most people use about 25–50% of the amount needed to achieve the labeled SPF.[60]
Directional
5In a systematic review, topical retinoids can reduce acne lesions by about 40–70% over 12 weeks.[61]
Single source
6Benzoyl peroxide reduces acne inflammatory lesions by 50–94% in clinical trials (range)[62]
Verified
7Topical corticosteroids reduce eczema severity by about 45–70% vs placebo in trials.[63]
Verified
8AAD states that sunscreen should be applied 15 minutes before going outside.[64]
Verified
9AAD states that you should reapply sunscreen every 2 hours (or after swimming/sweating).[64]
Directional

Product Formulation & Efficacy Interpretation

These dermatology facts deliver a mildly alarming punchline: while higher SPF only nudges UVB protection a bit (SPF 15 blocks about 93%, SPF 30 about 97%, SPF 50 about 98%), most people apply far less than the label expects and still need the basics done correctly by waiting 15 minutes before sun exposure and reapplying every two hours, because meanwhile acne and eczema treatments can genuinely move the needle in as little as 12 weeks (retinoids cutting lesions roughly 40 to 70%, benzoyl peroxide reducing inflammatory lesions about 50 to 94%, and topical corticosteroids lowering eczema severity about 45 to 70% versus placebo).

References

gminsights.comgminsights.com
  • 1gminsights.com/industry-analysis/dermatology-devices-market
  • 2gminsights.com/industry-analysis/dermatology-therapeutics-market
  • 3gminsights.com/industry-analysis/skincare-market
  • 4gminsights.com/industry-analysis/sunscreen-market
  • 5gminsights.com/industry-analysis/dermatology-skin-care-devices-market
  • 9gminsights.com/industry-analysis/psoriasis-therapeutics-market
  • 10gminsights.com/industry-analysis/eczema-treatment-market
  • 11gminsights.com/industry-analysis/hair-removal-market
  • 12gminsights.com/industry-analysis/led-light-therapy-market
  • 16gminsights.com/industry-analysis/epilating-and-shaving-market
  • 17gminsights.com/industry-analysis/dermocosmetics-market
alliedmarketresearch.comalliedmarketresearch.com
  • 6alliedmarketresearch.com/dermatology-market
  • 8alliedmarketresearch.com/acne-treatment-market
  • 13alliedmarketresearch.com/us-dermatology-market
  • 14alliedmarketresearch.com/europe-dermatology-market
  • 15alliedmarketresearch.com/asia-pacific-dermatology-market
grandviewresearch.comgrandviewresearch.com
  • 7grandviewresearch.com/industry-analysis/anti-aging-skin-care-market
statista.comstatista.com
  • 18statista.com/statistics/253342/uk-market-for-skin-care-products/
  • 19statista.com/statistics/195149/global-personal-care-market-forecast/
bio.orgbio.org
  • 20bio.org/policy/issues/biotech-innovation
who.intwho.int
  • 21who.int/news-room/fact-sheets/detail/skin-conditions
  • 22who.int/news-room/fact-sheets/detail/scabies
  • 34who.int/publications/i/item/9789241563546
nature.comnature.com
  • 23nature.com/articles/s41443-020-0292-4
ncbi.nlm.nih.govncbi.nlm.nih.gov
  • 24ncbi.nlm.nih.gov/pmc/articles/PMC5678665/
  • 25ncbi.nlm.nih.gov/pmc/articles/PMC4104227/
  • 26ncbi.nlm.nih.gov/pmc/articles/PMC5034542/
  • 27ncbi.nlm.nih.gov/pmc/articles/PMC5710943/
  • 28ncbi.nlm.nih.gov/pmc/articles/PMC5451002/
  • 29ncbi.nlm.nih.gov/pmc/articles/PMC5510970/
  • 30ncbi.nlm.nih.gov/pmc/articles/PMC4999756/
  • 31ncbi.nlm.nih.gov/pmc/articles/PMC4057039/
  • 32ncbi.nlm.nih.gov/pmc/articles/PMC4163231/
  • 33ncbi.nlm.nih.gov/pmc/articles/PMC4197815/
  • 54ncbi.nlm.nih.gov/pmc/articles/PMC7924764/
  • 55ncbi.nlm.nih.gov/pmc/articles/PMC5986342/
  • 56ncbi.nlm.nih.gov/pmc/articles/PMC8176208/
  • 57ncbi.nlm.nih.gov/pmc/articles/PMC8106086/
  • 59ncbi.nlm.nih.gov/pmc/articles/PMC6060490/
iarc.who.intiarc.who.int
  • 35iarc.who.int/news-events/faq-on-melanoma/
aad.orgaad.org
  • 36aad.org/media/news-releases/most-americans-are-affected-by-skin-conditions-aad-stats
  • 37aad.org/media/news-releases/skin-cancer-statistics
  • 38aad.org/public/diseases/acne/about/acne-statistics
  • 60aad.org/public/everyday-care/skin-care-basics/sun-screen/sunscreen-facts
  • 64aad.org/public/everyday-care/skin-care-basics/sun-screen/how-to-use-sunscreen
nationaleczema.orgnationaleczema.org
  • 39nationaleczema.org/eczema-facts/
psoriasis.orgpsoriasis.org
  • 40psoriasis.org/psoriasis-statistics/
naaf.orgnaaf.org
  • 41naaf.org/about-alopecia-areata/alopecia-areata-facts/
hs-foundation.orghs-foundation.org
  • 42hs-foundation.org/about-hs-facts/
ghdx.healthdata.orgghdx.healthdata.org
  • 43ghdx.healthdata.org/gbd-results-tool?params=gbd-api-GBD%202019
cdc.govcdc.gov
  • 44cdc.gov/nchs/fastats/rosacea.htm
  • 45cdc.gov/nchs/fastats/atopic-dermatitis.htm
  • 46cdc.gov/nchs/fastats/psoriasis.htm
  • 47cdc.gov/nchs/fastats/vitiligo.htm
  • 48cdc.gov/nchs/fastats/eczema.htm
peta.orgpeta.org
  • 49peta.org/blog/cruelty-free-statistics/
mckinsey.commckinsey.com
  • 50mckinsey.com/industries/consumer-packaged-goods/our-insights/the-sustainability-imperative
mintel.commintel.com
  • 51mintel.com/press-releases/global-sustainability-report
nielsen.comnielsen.com
  • 52nielsen.com/insights/2015/global-sustainability-study/
skincancer.orgskincancer.org
  • 53skincancer.org/prevention/uv-radiation/
issuu.comissuu.com
  • 58issuu.com/dermatology-times/docs
pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov
  • 61pubmed.ncbi.nlm.nih.gov/32181556/
  • 62pubmed.ncbi.nlm.nih.gov/19895711/
  • 63pubmed.ncbi.nlm.nih.gov/29018012/